Workplace Exercise and Well-Being in Radiologic Technologists

January 7, 2026 updated by: Pedro Ramalho

Effects of a Workplace Exercise Program on Stress, Burnout, and Quality of Life in Radiologic Technologists

Radiologic technologists often face demanding work conditions that contribute to elevated stress levels and increased burnout risk, ultimately affecting both their well-being and professional effectiveness. Workplace exercise initiatives have shown potential benefits for improving physical and psychological health; however, experimental research targeting this specific occupational group is still scarce. The main aim of this study is to evaluate the effects of a structured workplace exercise intervention on perceived stress, burnout, and quality of life among radiologic technologists. The secondary objective is to assess the effects of a detraining period on the same outcomes following completion of the exercise program.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
19

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Portugal
      • Castelo Branco, Portugal, 6000
        • Local Health Unit of Castelo Branco (ULSCB)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy radiographers (diagnostic and therapeutic imaging technologists)
  • Currently employed in the radiology department of the participating hospital
  • Voluntary participation with signed informed consent

Exclusion Criteria:

  • Presence of major musculoskeletal, cardiovascular, or neurological conditions that contraindicate physical exercise;
  • Pregnancy;
  • Unavailability to attend regular exercise sessions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Exercise group
Participants are involved in a workplace exercise program.
Behavioral: Workplace Exercise Program

Participants complete a six-week workplace exercise program comprising structured sessions based on methodologies described in previous studies (Alqhtani et al., 2023; Gelfman et al., 2024). Sessions are conducted three times per week, twice per day, with each session lasting approximately 15 to 20 minutes.

The program includes exercises primarily performed in a standing position and aims to improve flexibility, balance, and strength.

Flexibility training: Static and dynamic stretching exercises performed three times per week, 1-2 sets per exercise, held for 10-15 seconds each.

Balance training: Static and dynamic balance exercises performed three times per week, 1-3 sets per exercise, for 10-20 repetitions or 10-20 seconds over a 3-6 meter distance.

Strength training: Bodyweight and resistance exercises using auxiliary equipment (e.g., elastic bands), performed three times per week, 1-3 sets per exercise, 8-15 repetitions per set, with a slow to moderate tempo.
Other: Control group
Non-exercise group
Other: Control (Non-exercise)
Participants in the control (non-exercise) group maintain their usual work routines and will not participate in any structured exercise sessions during the study period.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Changes in Quality of Life Levels
Time Frame: From baseline to 6 weeks (end of the exercise program)
The World Health Organization Quality of Life - BREF (WHOQOL-BREF) was used. The Portuguese version was adapted and validated by Canavarro et al. (2007).
From baseline to 6 weeks (end of the exercise program)
Changes in Burnout Levels
Time Frame: From baseline to 6 weeks (end of the exercise program)
The Copenhagen Burnout Inventory (CBI), developed by Kristensen et al. (2005) and adapted for the Portuguese population by Fonte (2011), was used to assess burnout levels.
From baseline to 6 weeks (end of the exercise program)
Changes in Perceived Stress Levels
Time Frame: From baseline to 6 weeks (end of the exercise program)
The Perceived Stress Scale (PSS) was developed by Cohen, Kamarck, and Mermelstein (1983) and aims to measure an individual's subjective perception of stress intensity in their life - specifically, the degree to which situations are evaluated as unpredictable, uncontrollable, or overwhelming. The Portuguese version of the PSS-10 was validated by Trigo et al. (2010).
From baseline to 6 weeks (end of the exercise program)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Changes in quality of life, stress, and burnout
Time Frame: End of intervention (week 6) and after 4 weeks of detraining (week 10)
WHOQOL-BREF; Perceived Stress Scale; Copenhagen Burnout Inventory (CBI)
End of intervention (week 6) and after 4 weeks of detraining (week 10)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Pedro Ramalho

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
University of Beira Interior

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 14, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
October 30, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 1, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 25, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 25, 2025

First Posted (Estimated)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
December 8, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 9, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 7, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • EXER-RAD-2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

De-identified data that support the findings of this study may be made available from the corresponding author upon reasonable request and following approval by the Ethics Committee.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings